Gastroenterology Research and Practice

Translational Research in Inflammatory Bowel Diseases

Publishing date
01 Jun 2021
Submission deadline
05 Feb 2021

1University of Campinas, Campinas, Brazil

2University of Otago, Dunedin, New Zealand

3Quadram Institute, Norwich, UK

This issue is now closed for submissions.

Translational Research in Inflammatory Bowel Diseases

This issue is now closed for submissions.


Inflammatory bowel diseases, generally classified as Crohn's disease or ulcerative colitis, are characterized by chronic intestinal inflammation and increased morbidity. Recent evidence suggests that a defective immune response plays a significant role in their etiology. In addition, other factors may be involved, such as epigenetics, genetics, microbiome, nutritional, and environmental factors.

All of these discoveries have had an impact on how we understand this immune-mediated disease, and may help to improve clinical management and patient quality of life in the near future. The "bench to bedside and back to bench" philosophy has greatly contributed to pursue this purpose.

This Special Issue will emphasize translational research that is directly related to patient care. We invite researchers to contribute original research and review articles that deal with inflammatory bowel diseases at their molecular basis aiming at better diagnosis, prognosis and treatment.

Potential topics include but are not limited to the following:

  • Disease etiology
  • Biomarkers for diagnosis
  • Biological onset of disease and pre-clinical stage
  • The role of mesenteric adipose tissue in Crohn’s disease
  • Intestinal fibrosis and the inflammatory process
  • Biomarkers for follow-up, disease prognosis and postoperative outcomes
  • Molecular targets for novel treatments
  • Nutritional aspects for clinical intervention
  • Molecular biomarkers and correlation with endoscopic and imaging scores
  • Technical issues in endoscopic diagnosis (including capsule endoscopy)
  • Treatment of stricture by endoscopy (device-assisted enteroscopy)
  • Therapeutic drug monitoring
  • Assessment and management of extraintestinal manifestations
  • Emerging stem cell-based therapeutics
  • Ulcerative colitis and pouchitis
  • Fecal microbiota transplant
Gastroenterology Research and Practice
 Journal metrics
See full report
Acceptance rate5%
Submission to final decision98 days
Acceptance to publication22 days
Journal Citation Indicator0.370
Impact Factor2.0
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.